Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$3.80 USD
-0.07 (-1.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.80 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Earnings News For FATE
-
Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound?
-
Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y
-
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q4 Earnings Snapshot
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Fate Therapeutics (FATE) Up 10.3% Since Last Earnings Report: Can It Continue?
-
Fate Therapeutics: Q3 Earnings Snapshot
-
Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
-
Why Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?
-
Fate Therapeutics (FATE) Reports Q2 Loss, Lags Revenue Estimates
-
Fate Therapeutics: Q2 Earnings Snapshot
-
Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Down 17.8% Since Last Earnings Report: Can It Rebound?
-
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
-
Fate Therapeutics: Q1 Earnings Snapshot
-
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Why Is Fate Therapeutics (FATE) Down 8.9% Since Last Earnings Report?
-
Fate Therapeutics: Q4 Earnings Snapshot
-
Fate Therapeutics: Q4 Earnings Snapshot
-
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
-
Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates
-
Fate Therapeutics: Q3 Earnings Snapshot